Early results of Oxfords COVID-19 vaccine show promise

Researchers at Oxford University have confirmed that a vaccine, which is in the early stages of development, has shown promise. It is understood that the vaccine induces an immune reaction and is safe, but the team stressed that there is still a long road ahead.

Researchers tested the vaccine, which is in Phase 1/2 trial, on over 1,000 healthy adults. Their findings showed that the vaccine induced strong antibody and T cell immune responses for up to 56 days.

Speaking about the results, Professor Sarah Gilbert commented, “There is still much work to be done before we can confirm if our vaccine will help manage the Covid-19 pandemic, but these early results hold promise.”

She stressed, “As well as continuing to test our vaccine in phase-three trials, we need to learn more about the virus – for example, we still do not know how strong an immune response we need to provoke to effectively protect against Sars-Cov-2 infection. If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale.”

She added, “A successful vaccine against Sars-Cov-2 could be used to prevent infection, disease and death in the whole population, with high-risk populations such as hospital workers and older adults prioritised to receive vaccination.”

The study was published in The Lancet.




Hello Mama!
Help us help you by allowing us and our partners to remember your device as having browsed MummyPages and serve you better content and ads

We're on a mission to help our mums and their families thrive by informing, connecting and entertaining.

Join us in our mission by consenting to the use of cookies and IP address recognition by us and our partners to serve you content (including ads) best suited to your interests, both here and around the web.

We promise never to share any other information that may be deemed personal unless you explicitly tell us it's ok.

If you want more info, see our privacy policy.